Second Sight to Present at Investor Conference on June 4, 2015

Download as PDF

SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that the Company will present at the Three Part Advisors East Coast IDEAS Conference, as follows:

Presentation Date:   Thursday, June 4, 2015
Presentation Time: 3:10 p.m. EDT
Location: Boston Park Plaza, Boston, MA
 

The presentation will be webcast live and can be accessed at the conference website, http://wsw.com/webcast/threepa16/eyes, or in the Investor Relations section of the Company's website, secondsight.com.

About Second Sight

Second Sight's mission is to develop, manufacture and market innovative implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight has developed, and manufactures, the Argus® II Retinal Prosthesis intended to provide some useful vision to individuals with outer-retinal degenerations such as Retinitis Pigmentosa (RP). Patient enrollment is underway in a trial to test the safety and efficacy of the Argus II Retinal Prosthesis in patients with Dry Age-related Macular Degeneration. Second Sight is also developing the Orion™ I Visual Cortical Prosthesis to restore some vision to individuals who are blind due to causes other than preventable or treatable conditions. U.S. Headquarters are in Sylmar, CA, and European Headquarters are in Lausanne, Switzerland. For more information, visit www.secondsight.com.

Institutional Investor Relations:
In-Site Communications, Inc.
Lisa Wilson, 212-452-2793
President
lwilson@insitecony.com
or
Retail Investor Relations:
MZ North America
Matt Hayden, 949-259-4896
Chairman
matt.hayden@mzgroup.us

Source: Second Sight Medical Products, Inc.

Released May 27, 2015